Unplanned Return to the Operating Room in Orthopaedics: Closed-Loop Quality Improvement Programme (UROR-LOOP)
Effectiveness of a Hospital-Level Closed-Loop Management System for Unplanned Return to the Operating Room in Orthopaedics: A Multicentre, Prospective, Before-and-After Quality Improvement Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Haixue Wang
- Phone Number: +8613041196856
- Email: gwwanghaixue@126.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- A public secondary or tertiary general hospital or specialty hospital in China.
- Has an independent orthopaedic ward and an established orthopaedic surgical team.
- Has performed at least 2,000 orthopaedic surgical procedures per year during each of the previous three years.
- Is willing to participate in the study and sign the study cooperation agreement.
- The head of the orthopaedic department, or an authorized departmental representative, is willing to provide written informed consent on behalf of the participating department.
- Has accessible hospital discharge records, surgical and anaesthesia information systems, and the information infrastructure required for data verification.
- Is able to provide the required aggregated and de-identified study data and complete the scheduled follow-up assessments.
Exclusion Criteria:
- Is currently conducting a similar quality improvement programme that may affect the evaluation of the study intervention.
- Is unable to complete the required follow-up assessments or data reporting.
- Experiences or is expected to experience major institutional restructuring during the study period that may substantially affect implementation of the intervention.
The unit of enrollment, intervention, and analysis is the participating hospital and its orthopaedic department. Individual patients are not recruited as research participants. Only aggregated and de-identified hospital-level data will be collected.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Closed-Loop Management Programme for UROR in Orthopaedics
Participating orthopaedic departments will first undergo a baseline assessment of their existing management and reporting practices for unplanned return to the operating room.
They will then implement a standardized hospital-level closed-loop quality improvement programme.
The programme includes standardizing the definition of unplanned return to the operating room, establishing a non-punitive reporting mechanism, appointing a departmental coordinator, conducting multi-source data verification, organizing regular department-wide case reviews and root-cause analyses, and developing and implementing continuous quality improvement actions.
Implementation fidelity will be assessed quarterly, and study outcomes will be evaluated every six months during the 36-month study period.
|
This hospital-level organizational and behavioral quality improvement intervention aims to improve the management of unplanned return to the operating room in orthopaedics.
Following standardized training and system establishment, participating departments will implement a closed-loop management programme comprising six components: a standardized definition; a non-punitive reporting mechanism; appointment of a departmental coordinator; monthly case registration and multi-source verification using departmental records, adverse-event reporting systems, medical records, and surgical or anaesthesia information systems; regular department-wide case review and root-cause analysis; and development, implementation, and follow-up of continuous improvement actions.
The programme will operate continuously, with monthly management activities and quarterly adherence assessments.
It does not alter clinical treatment or require additional diagnostic or therapeutic procedures.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Underreporting Rate of Unplanned Return to the Operating Room in Orthopaedics
Time Frame: Baseline and 12, 24, and 36 months after implementation
|
The percentage of verified cases of unplanned return to the operating room (UROR) that were not reported through the designated hospital reporting pathway during each assessment period.
UROR cases will be identified and verified by cross-checking departmental case registries, hospital adverse-event reporting systems, medical records, and surgical or anaesthesia information systems.
The underreporting rate will be calculated as the number of verified UROR cases not formally reported divided by the total number of verified UROR cases, multiplied by 100%.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Implementation Rates of Predefined Closed-Loop Management Components
Time Frame: Baseline and 12, 24, and 36 months after implementation
|
At each assessment, the implementation rate of each prespecified closed-loop management component will be calculated separately as the number of participating orthopaedic departments meeting the component-specific implementation criterion divided by the total number of departments assessed, multiplied by 100%.
Components include: appointment of a designated departmental coordinator; completion of a standardized UROR case registry; multi-source case verification; completion of standardized case-review records; department-wide review of verified UROR cases; and documented development, implementation, and follow-up of quality improvement actions.
Results will be reported separately for each component.
|
Baseline and 12, 24, and 36 months after implementation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Unplanned Return to the Operating Room in Orthopaedics
Time Frame: Baseline and 12, 24, and 36 months after implementation
|
The percentage of orthopaedic surgical procedures followed by a verified unplanned return to the operating room during each assessment period.
The rate will be calculated as the number of verified UROR cases divided by the total number of orthopaedic surgical procedures performed during the same period, multiplied by 100%.
A verified UROR includes an unplanned repeat operation within 31 days of the original procedure, during the same hospitalization or following readmission, and excludes preplanned staged procedures.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Rates of Predefined Postoperative Complications in Orthopaedics
Time Frame: Baseline and 12, 24, and 36 months after implementation
|
The percentage of orthopaedic surgical patients experiencing each prespecified postoperative complication during the assessment period.
Complications include bleeding or haematoma, surgical site or other postoperative infection, venous thromboembolism, implant-related complications, drainage-related complications, and other protocol-defined complications.
The rate for each complication will be calculated separately as the number of patients with the complication divided by the total number of orthopaedic surgical patients, multiplied by 100%.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Unplanned Readmission Rate After Orthopaedic Surgery
Time Frame: Baseline and 12, 24, and 36 months after implementation
|
The percentage of orthopaedic surgical patients who experience an unplanned readmission after discharge during the prespecified follow-up period.
The rate will be calculated as the number of patients with an unplanned readmission divided by the total number of discharged orthopaedic surgical patients eligible for assessment, multiplied by 100%.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Mean Length of Hospital Stay Among Orthopaedic Surgical Patients
Time Frame: Baseline and 12, 24, and 36 months after implementation
|
The hospital-level mean length of stay among orthopaedic surgical patients during each assessment period.
Length of stay will be calculated from the date of hospital admission to the date of discharge and summarized in days using aggregated hospital-level data.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Mean Hospitalization Cost Among Orthopaedic Surgical Patients
Time Frame: Baseline and 12, 24, and 36 months after implementation
|
The hospital-level mean total hospitalization cost among orthopaedic surgical patients during each assessment period.
Total hospitalization cost will be obtained from the participating hospital's standardized administrative or medical record data and reported using aggregated hospital-level data in Chinese yuan.
|
Baseline and 12, 24, and 36 months after implementation
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PKUTH-ORTHO-UROR-M20260618
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.